EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Similar usage of T‐cell receptor β‐chain between tumor and adjacent normal tissue in hepatocellular carcinoma

Jie-Zuan Yang iD, Shao-Yan Xu, Dang-Sheng Xiao, Jin-You Li, Xiu-Yuan Jin, Dong Yan

Cancer Medicine · 2024-08 · 13 (16)

DOI: 10.1002/cam4.70121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 27.08.2024. Verfasst von Jie-Zuan Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Natio…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Receptors, Antigen, T-Cell, alpha-beta, Complementarity Determining Regions. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural Science Foundation of Zhejiang Province, Zhejiang Province Traditional Chinese Medicine Science and Technology Plan Project, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In this study, we comprehensively profiled the T‐cell receptor (TCR) repertoire of the tumor and adjacent normal tissue in patients with HBV‐associated hepatocellular carcinoma (HCC) and determined the baseline characteristics and clinical significance of TCR.

Methods

High‐throughput sequencing was used to determine the profile of complementarity‐determining region 3 (CDR3) of the TCR‐β chain variable (TRBV) in the tumor and normal tissue samples of 14 HCC patients. At the same time, TRBV diversity and differences in expression between tumor and normal tissues were investigated. The cumulative frequency of top 100 CDR3 (CF100), clonality, and Shannon entropy as indices to evaluate diversity, Results The diversity of TRBV CDR3 showed no significant difference between tumor and normal tissues. Of the 58 V gene segments in TRBV, TRBV16 and TRBV7‐6 had a significantly higher frequency in the tumor group than in the normal group ( p < 0.05). The frequency of 14 J gene segments showed no significant difference between tumor and normal tissues. In contrast, the frequency of 22 TRBVx/BJx combinations was significantly higher in the tumor than in the normal tissue. In addition, the length and type of TRBV CDR3 were similar in tumor and normal tissues, and a Gaussian distribution was observed in both groups.

Conclusion

This study provided a large amount of information about the TCR lineage in HBV‐associated HCC, laying the foundation for further research. In addition, the fact that the immune repertoire (TRBV CDR3) hardly differs between tumor and adjacent normal tissue provides a new clue for exploring the mechanism of the liver as an organ with immune privileges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsReceptors, Antigen, T-Cell, alpha-betaComplementarity Determining RegionsHumansMaleMiddle AgedFemaleHigh-Throughput Nucleotide SequencingAdultAged

Stichwörter der Autor:innen

T‐cell receptor β‐chaincomplementarity determining region 3hepatocellular carcinomaimmune privilegeimmune repertoire

Substanzen

Receptors, Antigen, T-Cell, alpha-betaComplementarity Determining Regions

Autor:innen und Institutionen

  • The First Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Hangzhou, China.
  • Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Key Laboratory of Diagnosis and Treatment of Aging and Physic-Chemical Injury Diseases of Zhejiang Province, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

ORCID-Profile: Jie-Zuan Yang

Förderung

  • the Natural Science Foundation of Zhejiang Province
  • Zhejiang Province Traditional Chinese Medicine Science and Technology Plan Project
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Yang, J. Z., Xu, S. Y., Xiao, D. S., Li, J. Y., Jin, X. Y., & Yan, D. (2024). Similar usage of T‐cell receptor β‐chain between tumor and adjacent normal tissue in hepatocellular carcinoma. Cancer Medicine, 13(16). https://doi.org/10.1002/cam4.70121

Vancouver

Yang JZ, Xu SY, Xiao DS, Li JY, Jin XY, Yan D. Similar usage of T‐cell receptor β‐chain between tumor and adjacent normal tissue in hepatocellular carcinoma. Cancer Medicine. 2024;13(16). doi:10.1002/cam4.70121

BibTeX
@article{Yang2024,
  author = {Yang, Jie-Zuan and Xu, Shao-Yan and Xiao, Dang-Sheng and Li, Jin-You and Jin, Xiu-Yuan and Yan, Dong},
  title = {Similar usage of T‐cell receptor β‐chain between tumor and adjacent normal tissue in hepatocellular carcinoma},
  journal = {Cancer Medicine},
  year = {2024},
  volume = {13},
  number = {16},
  doi = {10.1002/cam4.70121}
}
Kostenlos starten →